iShares U.S. Pharmaceutical ETF (IHE)
Seasonality Analysis
iShares U.S. Pharmaceutical ETF Annual Seasonality Statistics
iShares U.S. Pharmaceutical ETF Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 0.10% | Moderate | |
| February | 0.05% | Moderate | |
| March | -0.02% | Very Weak | |
| April | 1.43% | Moderate | |
| May | 0.64% | Moderate | |
| June | 0.87% | Moderate | |
| July | 1.07% | Moderate | |
| August | 0.58% | Moderate | |
| September WORST | -0.81% | Weak | |
| October | -0.50% | Weak | |
| November BEST | 2.83% | Strong | |
| December | 1.28% | Moderate |
iShares U.S. Pharmaceutical ETF 2026 vs Historical Pattern
iShares U.S. Pharmaceutical ETF Interactive Seasonality Chart
iShares U.S. Pharmaceutical ETF Pattern Scanner
iShares U.S. Pharmaceutical ETF Seasonal Historical Performance
About iShares U.S. Pharmaceutical ETF (IHE) Seasonality
iShares U.S. Pharmaceutical ETF (IHE) has been analyzed using 20 years of historical data to identify seasonal patterns. Classified under ETFs, iShares U.S. Pharmaceutical ETF shows distinct seasonal tendencies based on historical data.
The strongest month for iShares U.S. Pharmaceutical ETF is historically November, with an average return of 2.83% and a win rate of 80%. Conversely, September tends to be the weakest month, averaging -0.81% return.
Looking at the full calendar year, iShares U.S. Pharmaceutical ETF has an average annual return of 7.51% with an overall monthly win rate of 59.2%. Out of 12 months, 9 typically show positive average returns.
The seasonal pattern for iShares U.S. Pharmaceutical ETF has a consistency score of 48.7 (Poor), based on 21 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
iShares U.S. Pharmaceutical ETF Seasonality FAQ
What is the best month to buy iShares U.S. Pharmaceutical ETF (IHE)?
Historically, November has been the best month for iShares U.S. Pharmaceutical ETF, with an average return of 2.83% and a win rate of 80%. However, past performance does not guarantee future results.
What is the worst month for iShares U.S. Pharmaceutical ETF (IHE)?
Based on historical data, September has been the weakest month for iShares U.S. Pharmaceutical ETF, with an average return of -0.81%. This is a historical observation and does not guarantee future results.
How reliable is IHE seasonality data?
The seasonality analysis for iShares U.S. Pharmaceutical ETF is based on 20 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use iShares U.S. Pharmaceutical ETF seasonality in my trading?
Use iShares U.S. Pharmaceutical ETF (IHE) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.